Skip to content

Effect of Rose Essence on women's sexual dysfunction and happiness

Effect of Rose essence on improving sexual dysfunction and increase happiness in women treated with methadone

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015091523705N2
Enrollment
60
Registered
2015-10-30
Start date
2015-09-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sexual dysfunction. Sexual dysfunction, not caused by organic disorder or disease

Interventions

Intervention 1: The control group will receive a placebo capsule daily. Intervention 2: In the experimental group, the participants will receive daily one capsule of rose essence.
Placebo
Treatment - Drugs
The control group will receive a placebo capsule daily.
In the experimental group, the participants will receive daily one capsule of rose essence

Sponsors

Vice chancellor for research, Kermanshah University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 48 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: patients undergoing methadone treatment; minimum elementary education; married; age between 20-48 years; lack of sexual problems before treatment with methadone. Exclusion criteria: allergy to products made from rose essence; history of any endocrine disease such as elevated prolactine, thyroid disorders, and change in sexual activity because of pregnancy of wife, remarriage, and divorce.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Sexual dysfunction. Timepoint: The beginning of the study (baseline), week four and end of the study (week eight). Method of measurement: Based on sexual function questionnaire (FSFI ).;Happiness. Timepoint: The beginning of the study (baseline), week four and end of the study (week eight). Method of measurement: Based on happiness questionnaire.;Level of the hormone. Timepoint: Beginning and end of the study (week eight). Method of measurement: By Blood Test.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Vahid Farnia

Kermanshah University of Medical Sciences

vfarnia@yahoo.com0083309125188875

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026